Ezitin (Ezetimibe)

Ezetimibe is a widely prescribed lipid‑lowering medication used to reduce elevated LDL cholesterol levels in patients with hypercholesterolemia. Unlike statins, which work in the liver, ezetimibe acts in the small intestine to block the absorption of cholesterol from food and bile. This complementary mechanism makes it especially valuable for patients who cannot tolerate high‑dose statins or who require additional LDL reduction despite statin therapy. Ezetimibe is recommended in major clinical guidelines as an add‑on therapy for high‑risk patients, including those with atherosclerotic cardiovascular disease, diabetes, or familial hypercholesterolemia. It is generally well tolerated, with a low incidence of muscle‑related side effects, making it a suitable option for long‑term cholesterol management.

Indications / Usage

Ezetimibe is used for:

• Primary hypercholesterolemia (alone or with statins)
• Familial hypercholesterolemia (usually combined with high‑intensity statins)
• Mixed dyslipidemia
• Sitosterolemia (rare genetic disorder with elevated plant sterols)
• Patients intolerant to statins or requiring additional LDL reduction

Clinical goals typically include lowering LDL‑C, reducing cardiovascular risk, and improving lipid profiles.